SOUTH
SAN FRANCISCO, Calif. and VANCOUVER, Canada, Nov. 8, 2023
/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX),
a clinical-stage pharmaceutical company focused on developing novel
therapies for the treatment of prostate cancer, today announced
that the Company will be presenting at the Jefferies
Healthcare Conference on Wednesday, November 15,
2023, at 8:30 a.m. GMT/ 3:30 a.m.
ET in London.
David. R. Parkinson, President, and Chief Executive Officer;
Peter Virsik, Chief Operating
Officer; and David S. Wood, Chief Financial Officer, will host
and participate in one-on-one meetings.
A live webcast of the Jefferies presentation can be accessed in
the Investors/Events & Presentations section of ESSA's website
at www.essapharma.com. Following the event, the webcast will
be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please
visit www.essapharma.com, and follow us on Twitter and
LinkedIn.
Contacts
ESSA Pharma, Inc.
Peter Virsik
Chief Operating Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-jefferies-london-healthcare-conference-301980837.html
SOURCE ESSA Pharma Inc